Mediators of Inflammation
Volume 2008 (2008), Article ID 164134, 8 pages
doi:10.1155/2008/164134
Clinical Study

Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure

Elias J. Gialafos,1,2 Ioannis Moyssakis,1 Theodora Psaltopoulou,3 Dimitrios P. Papadopoulos,1 Despoina Perea,2 Kostantinos Vlasis,2 Charalampos Kostopoulos,4 Vassilios Votteas,1 and Petros P. Sfikakis2

1Cardiology Department, Laikon General Hospital, University of Athens Medical School, 115 27 Athens, Greece
2First Department of Propaedeutic and Internal Medicine, University of Athens Medical School, 115 27 Athens, Greece
3Department of Hygiene and Epidemiology, University of Athens Medical School, 115 27 Athens, Greece
4Pulmonary Unit, Department of Therapeutics, University of Athens Medical School, 115 27 Athens, Greece

Received 31 May 2008; Revised 14 October 2008; Accepted 28 October 2008

Academic Editor: Yona Keisari

Copyright © 2008 Elias J. Gialafos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Elias J. Gialafos, Ioannis Moyssakis, Theodora Psaltopoulou, et al., “Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure,” Mediators of Inflammation, vol. 2008, Article ID 164134, 8 pages, 2008. doi:10.1155/2008/164134